Reducing Episodes by Septal Pacing Efficacy Confirmation Trial (RESPECT)

Completed · Not applicable

Conditions studied: Atrial Fibrillation, Tachycardia, Supraventricular, Arrhythmia, Bradycardia

In brief

The purpose of this study is to find out if specialized programs in the AT500 and EnRhythm pacemakers will reduce the number of irregular heartbeat in the upper chamber of the heart and reduce symptoms (such as shortness of breath, dizziness, and others).

Key facts

Study ID

NCT00289289

Run by

Medtronic Cardiac Rhythm and Heart Failure

People needed

400

Starts

2004-02-01

Expected to finish

2011-07-01

Last updated by the study team

2012-08-08

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Subjects with fast and/or slow heartbeats who are in need of dual chamber pacing (pacing in both the atria and ventricles) as determined by their doctor.
• Subjects who have a history of occasional fast heartbeats originating from the upper heart chambers.
• Subjects who have experienced at least two symptomatic episodes of fast heartbeats three months prior to enrollment.
• Subjects that are expected to stay on the same heart medications during the length study.

You may not qualify if…

• Subjects who have permanent (chronic) or persistent (not self-terminating) atrial fibrillation (fast heartbeats originating from the upper heart chambers).
• Subjects who have atrial fibrillation due to a reversible cause, i.e. electrolyte imbalance.
• Subjects who are current or immediate implantable cardioverter defibrillator (ICD) recipients.

Where it is running

• Study site — Little Rock, Arkansas, United States
• Study site — Rancho Mirage, California, United States
• Study site — San Diego, California, United States
• Study site — Yuba City, California, United States
• Study site — Colorado Springs, Colorado, United States
• Study site — Jacksonville, Florida, United States
• Study site — Lakeland, Florida, United States
• Study site — Chicago, Illinois, United States
• Study site — Decatur, Illinois, United States
• Study site — Urbana, Illinois, United States
• Study site — Indianapolis, Indiana, United States
• Study site — Cedar Rapids, Iowa, United States
• Study site — Louisville, Kentucky, United States
• Study site — Owensboro, Kentucky, United States
• Study site — Takoma Park, Maryland, United States
• Study site — Springfield, Massachusetts, United States
• Study site — Minneapolis, Minnesota, United States
• Study site — Clifton, New Jersey, United States
• Study site — Morristown, New Jersey, United States
• Study site — Albuquerque, New Mexico, United States
• Study site — Mineola, New York, United States
• Study site — Charlotte, North Carolina, United States
• Study site — Cleveland, Ohio, United States
• Study site — Columbus, Ohio, United States
• Study site — Hershey, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.